| Product Code: ETC6520091 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of amlodipine besylate in Brunei from top exporting countries such as China, Germany, India, Japan, and Malaysia in 2024 indicate a continued reliance on these key suppliers. Despite a significant decline in the Compound Annual Growth Rate (CAGR) from 2020 to 2024, the High Herfindahl-Hirschman Index (HHI) suggests a market structure with very high concentration. The sharp negative growth rate in 2024 highlights potential challenges or shifts in the market dynamics that importers and stakeholders in Brunei should monitor closely.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Amlodipine Besylate Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Amlodipine Besylate Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Amlodipine Besylate Market - Industry Life Cycle |
3.4 Brunei Amlodipine Besylate Market - Porter's Five Forces |
3.5 Brunei Amlodipine Besylate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Brunei Amlodipine Besylate Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Brunei Amlodipine Besylate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and cardiovascular diseases in Brunei |
4.2.2 Growing awareness about the benefits of amlodipine besylate for treating hypertension |
4.2.3 Government initiatives promoting healthcare access and affordability |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Competition from other hypertension medications in the market |
4.3.3 Potential side effects associated with amlodipine besylate impacting adoption rates |
5 Brunei Amlodipine Besylate Market Trends |
6 Brunei Amlodipine Besylate Market, By Types |
6.1 Brunei Amlodipine Besylate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Brunei Amlodipine Besylate Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Brunei Amlodipine Besylate Market Revenues & Volume, By 2.5mg Tablets, 2021- 2031F |
6.1.4 Brunei Amlodipine Besylate Market Revenues & Volume, By 5mg Tablets, 2021- 2031F |
6.1.5 Brunei Amlodipine Besylate Market Revenues & Volume, By 10mg Tablets., 2021- 2031F |
6.2 Brunei Amlodipine Besylate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Brunei Amlodipine Besylate Market Revenues & Volume, By High Blood Pressure, 2021- 2031F |
6.2.3 Brunei Amlodipine Besylate Market Revenues & Volume, By Heart Diseases, 2021- 2031F |
7 Brunei Amlodipine Besylate Market Import-Export Trade Statistics |
7.1 Brunei Amlodipine Besylate Market Export to Major Countries |
7.2 Brunei Amlodipine Besylate Market Imports from Major Countries |
8 Brunei Amlodipine Besylate Market Key Performance Indicators |
8.1 Prescription rates of amlodipine besylate by healthcare providers |
8.2 Patient adherence rates to amlodipine besylate treatment regimens |
8.3 Number of healthcare facilities offering amlodipine besylate as a primary hypertension treatment option |
9 Brunei Amlodipine Besylate Market - Opportunity Assessment |
9.1 Brunei Amlodipine Besylate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Brunei Amlodipine Besylate Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Brunei Amlodipine Besylate Market - Competitive Landscape |
10.1 Brunei Amlodipine Besylate Market Revenue Share, By Companies, 2024 |
10.2 Brunei Amlodipine Besylate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |